Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sugar Balance for Blood Sugar Control
NCT02866539Completed
- Sponsor
- Composite Interceptive Med-Science Laboratories
- Start
- Dec 2016
- Primary completion
- Dec 2017
- Countries
- 1
01
Overview
Randomised, double-blind trial (2 arms), sponsored by Composite Interceptive Med-Science Laboratories. Primary endpoints: Number of diabetes subjects achieving glycemic control at 6 months and Number of pre-diabetes achieving euglycemic status at 6 months. Started Dec 2016; status: completed.
Beyond the preview
Go deeper on NCT02866539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02866539.